Ocular Toxicities of Targeted Cancer Therapies
Physician's Weekly
JUNE 15, 2025
As the use of novel targeted therapies continues to expand, a growing body of evidence has linked these treatments to a range of ocular complications that may significantly affect patient quality of life and treatment adherence. These recommendations are designed to be practical and adaptable to various clinical settings.
Let's personalize your content